Skip to main content

Advertisement

Log in

Role of PET/CT in the detection of liver metastases from colorectal cancer

Ruolo della PET/TC nel rilevamento delle metastasi epatiche da carcinoma del colon-retto

  • Abdominal Radiology/Radiologia Addominale
  • Published:
La radiologia medica Aims and scope Submit manuscript

Abstract

Purpose

The aim of this study was to compare the diagnostic accuracy of 2-[fluorine-18] fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG-PET) and computed tomography (CT) with PET/CT in the detection of liver metastases during tumour staging in patients suffering from colorectal carcinoma for the purposes of correct surgical planning and follow-up.

Materials and methods

A total of 467 patients underwent a PET/CT scan using an iodinated contrast medium. We compared images obtained by the single PET scan, the single CT scan and by the fusion of the two procedures (PET/CT). The final diagnosis was obtained by histological examination and/or by the follow-up of all patients, including those who did not undergo surgery or biopsy.

Results

The PET scan had 94.05% sensitivity, 91.60% specificity and 93.36% accuracy; the CT scan had 91.07% sensitivity, 95.42% specificity and 92.29% accuracy. The combined procedures (PET/CT) had the following values: sensitivity 97.92%, specificity 97.71% and accuracy 97.86%.

Conclusions

This study indicates that PET/CT is very useful in staging and restaging patients suffering from colorectal cancer. It was particularly useful when recurrences could not be visualised either clinically or by imaging despite increasing tumour markers, as it guaranteed an earlier diagnosis. PET/CT not only provides high diagnostic performance in terms of sensitivity and specificity, enabling modification of patient treatment, but it is also a unique, high-profile procedure that can produce cost savings.

Riassunto

Obiettivo

Comparare l’accuratezza diagnostica della 18F-FDG-PET e della TC con quella della PET/TC nel rilievo di metastasi epatiche in pazienti affetti da carcinoma del colon-retto in fase di staging ai fini di un corretto planning chirurgico e follow-up.

Materiali e metodi

Sono stati valutati 467 pazienti mediante PET/TC effettuata con somministrazione di MdC organoiodato. È stata effettuata una comparazione tra le immagini ottenute dalla sola rilevazione PET, dalla sola rilevazione TC e quelle ottenute mediante fusione PET/TC. La diagnosi definitiva è stata ottenuta mediante conferma istologica e/o attraverso il follow-up di tutti i pazienti, anche di quelli non sottoposti a procedure bioptiche o ad intervento chirurgico.

Risultati

La tecnica PET è risultata avere una sensibilità pari al 94,05%, una specificità pari al 91,60% ed un’accuratezza del 93,36%; la tecnica TC una sensibilità pari al 91,07%, una specificità pari al 95,42% ed un’accuratezza del 92,29%. La tecnica combinata (PET/TC) è risultata avere una sensibilità pari al 97,92%, una specificità pari al 97,71%, ed un’accuratezza del 97,86%.

Conclusioni

La PET/TC è risultata di notevole utilità nella stadiazione e ristadiazione dei pazienti affetti da tumore del colon-retto. Essa è risultata particolarmente efficace quando, pur in presenza di un innalzamento progressivo dei marcatori, non era visualizzabile clinicamente o strumentalmente ripresa di malattia, garantendo così un’anticipazione diagnostica. La PET/TC non solo offre una performance diagnostica ottimale in termini di sensibilità e specificità, permettendo peraltro di modificare l’iter terapeutico del paziente, ma riveste anche caratteri di indagine unica di elezione, con conseguenti risparmi economici.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References/Bibliografia

  1. Parker SL, Tong T, Bolden S, Wingo PA (1997) Cancer statistics. CA Cancer J Clin 47:5–27

    Article  PubMed  CAS  Google Scholar 

  2. Piano oncologico nazionale (2004–2006) Commissione Oncologica Nazionale — Ministero Salute. D.M. 26-5-2004 p.5

  3. Abdel-Nabi H, Doerr RJ, Lamonica DM et al (1998) Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 206:755–760

    PubMed  CAS  Google Scholar 

  4. Arulampalam TH, Francis DL, Visvikis D et al (2004) FDG-PET for the preoperative evaluation of colorectal liver metastases. Eur J Surg Oncol 30:286–291

    Article  PubMed  CAS  Google Scholar 

  5. Fong Y, Cohen AM, Fortner JG et al (1997) Liver resection for colorectal metastases. J Clin Oncol 15:938–946

    PubMed  CAS  Google Scholar 

  6. Wanebo HJ, Chu QD, Vezeridis MP, Soderberg C (1996) Patient selection for hepatic resection of colorectal metastases. Arch Surg 131:322–329

    PubMed  CAS  Google Scholar 

  7. Selzner M, Hany TF, Wildbrett P et al (2004) Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 240:1027–1034

    Article  PubMed  Google Scholar 

  8. Gearhart SL, Frassica D, Rosen R et al (2006) Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer. Ann Surg Oncol 13:397–404

    Article  PubMed  Google Scholar 

  9. Kim EE, Chung SK, Haynie TP et al (1992) Differentiation of residual or recurrent tumors from post-treatment changes with F18 FDG PET. Radiographics 12:269–279

    PubMed  CAS  Google Scholar 

  10. Rohren EM, Turkington TG, Coleman RE (2004) Clinical applications of PET in oncology. Radiology 231:305–332

    Article  PubMed  Google Scholar 

  11. Townsend DW, Cherry SR (2001) Combining anatomy and function: the path to true image fusion. Eur Radiol 11:1968–1974

    Article  PubMed  CAS  Google Scholar 

  12. Hutton BF, Braun M (2003) Software for image registration: algorithms, accuracy, efficacy. Semin Nucl Med 33:180–192

    Article  PubMed  Google Scholar 

  13. Townsend DW, Beyer T, Blodgett TM (2003) PET/CT scanners: a hardware approach to image fusion. Semin Nucl Med 33:193–204

    Article  PubMed  Google Scholar 

  14. Pauwels EK, McCready VR, Stoot JH, van Deurzen DF (1998) The mechanism of accumulation of tumour-localising radiopharmaceuticals. Eur J Nucl Med 25:277–305

    Article  PubMed  CAS  Google Scholar 

  15. Wahl RL, Hutchins GD, Buchsbaum DJ et al (1991) 18 F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography. Cancer 67:1544–1550

    Article  PubMed  CAS  Google Scholar 

  16. Lai CH, Yen TC, Chang TC (2007) Positron-emission tomography imaging for gynecologic malignancy. Curr Opin Obstet Gynecol 19:37–41

    Article  PubMed  Google Scholar 

  17. Kostakoglu L, Agress H Jr, Goldsmith SJ (2003) Clinical role of FDG PET in evaluation of cancer patients. Radiographics 23:315–340

    Article  PubMed  Google Scholar 

  18. Fong Y, Saldinger PF, Akhurst T et al (1999) Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg 178:282–287

    Article  PubMed  CAS  Google Scholar 

  19. Imdahl A, Reinhardt MJ, Nitzsche EU et al (2000) Impact of 18F-FDG-positron emission tomography for decision making in colorectal cancer recurrences. Arch Surg 385:129–134

    Article  CAS  Google Scholar 

  20. Wiering B, Ruers TJ, Oyen WJ (2004) Role of FDG-PET in the diagnosis and treatment of colorectal liver metastases. Expert Rev Anticancer Ther 4:607–613

    Article  PubMed  Google Scholar 

  21. Kim JH, Czernin J, Allen-Auerbach MS et al (2005) Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer. J Nucl Med 46:587–595

    PubMed  Google Scholar 

  22. Martinelli M, Townsend D, Meltzer C, Villemagne V (2000) Survey of results of whole body imaging using the PET/CT at the University of Pittsburgh Medical Center PET Facility. Clin Positron Imaging 3:161

    Article  PubMed  Google Scholar 

  23. Charron M, Beyer T, Bohnen NN et al (2000) Image analysis in patients with cancer studied with a combined PET and CT scanner. Clin Nucl Med 25:905–910

    Article  PubMed  CAS  Google Scholar 

  24. Cohade C, Osman M, Leal J, Wahl RL (2003) Direct comparison of (18)FFDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 44:1797–1803

    PubMed  Google Scholar 

  25. Steele G Jr, Bleday R, Mayer RJ et al (1991) A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584. J Clin Oncol 9:1105–1112

    PubMed  Google Scholar 

  26. Kapoor V, McCook BM, Torok FS (2004) An introduction to PET-CT imaging. Radiographics 24:523–543

    Article  PubMed  Google Scholar 

  27. Heriot AG, Grundy A, Kumar D (1999) Preoperative staging of rectal carcinoma. Br J Surg 86:17–28

    Article  PubMed  CAS  Google Scholar 

  28. Delbeke D, Martin WH (2004) PET and PET-CT for evaluation of colorectal carcinoma. Semin Nucl Med 34:209–223

    Article  PubMed  Google Scholar 

  29. Rohren EM, Paulson EK, Hagge R et al (2002) The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer. Clin Nucl Med 27:550–555

    Article  PubMed  Google Scholar 

  30. Delbeke D, Martin WH, Patton JA, Sandler MP (2001) Value of iterative reconstruction, attenuation correction, and image fusion in the interpretation of FDG PET images with an integrated dual-head coincidence camera and X-ray-based attenuation maps. Radiology 218:163–171

    PubMed  CAS  Google Scholar 

  31. Flamen P (2002) Positron emission tomography in colorectal cancer. Best Pract Res Clin Gastroenterol 16:237–251

    Article  PubMed  Google Scholar 

  32. Park KC, Schwimmer J, Shepherd JE et al (2001) Decision analysis for the cost-effective management of recurrent colorectal cancer. Ann Surg 233:310–319

    Article  PubMed  CAS  Google Scholar 

  33. Berthelsen AK, Holm S, Loft A et al (2005) PET/CT with intravenous contrast cam be used for PET attenuation correction in cancer patients. Eur J Nucl Med Mol Imaging 32:1167–1175

    Article  PubMed  CAS  Google Scholar 

  34. Czernin J, Schelbert H (2004) PET/CT imaging: facts, opinions, hopes, and questions. J Nucl Med 45:1S–3S

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Orlacchio.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Orlacchio, A., Schillaci, O., Fusco, N. et al. Role of PET/CT in the detection of liver metastases from colorectal cancer. Radiol med 114, 571–585 (2009). https://doi.org/10.1007/s11547-009-0393-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11547-009-0393-7

Keywords

Parole chiave

Navigation